GlobeNewsWire
12 Jan 2026, 13:30 UTC · 35w ago
Verdict
Headline takes no side. We score HYD +0.70 across three claims — strongly bullish.
+0.70strongly bullish
More positive than 81% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Picard Medical (PMI) and Hydrix (HYD) have entered a collaboration to develop the 'Emperor,' a next-generation, fully implantable Total Artificial Heart.
More positive than 85% of claims this week
The collaboration may allow Picard Medical to access Australian R&D tax incentives of approximately 43% of eligible expenditures.
So whatSignificant tax credits reduce the capital burn rate for a high-cost R&D project, improving the company's financial runway.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 65% of claims this week
The development program is structured in stages, with the initial phase running through the end of 2026 and future stages contingent on technical and regulatory milestones.
More positive than 45% of claims this week
Which stocks this story touches
More positive than 81% of ticker scores this week
The company secured a development collaboration agreement, endorsing its capability to deliver complex medical device programs.
More positive than 75% of ticker scores this week
The company is advancing its next-generation artificial heart technology and may benefit from significant R&D tax incentives.
More positive than 56% of relationship scores this week
[mutual] Picard Medical and Hydrix entered into a development collaboration agreement to advance the Emperor Total Artificial Heart technology.
More positive than 35% of relationship scores this week
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
3h ago
[a_to_b] Hydrix will perform complex critical engineering and development work for Picard Medical.
−4.9%
Price is moving against the score
$48.82 vs $51.31 close before publication (Jan 9) · not market-adjusted
HYD chart →
